Xiaojing Xing
Liaoning Cancer Hospital & Institute(CN)
Publications by Year
Research Areas
Dermatologic Treatments and Research, Systemic Sclerosis and Related Diseases, Autoimmune Bullous Skin Diseases, Inflammatory Myopathies and Dermatomyositis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction(2014)147 cited
- → IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway(2013)90 cited
- → Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis(2020)67 cited
- → Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway(2014)54 cited
- → IFN‐γ+IL‐17+Th17 cells regulate fibrosis through secreting IL‐21 in systemic scleroderma(2020)37 cited
- → Medical expenditure for liver cancer in urban China(2018)35 cited
- → Efficacy and Influence Factors of 308‐nm Excimer Lamp with Minoxidil in the Treatment of Alopecia Areata(2020)10 cited
- → The correlation between Ro-52 antibody and interstitial lung disease in dermatomyositis(2020)
- → Efficacy and safety of zanubrutinib combined with anti-CD20 monoclonal antibody-based regimens as first-line therapy in high-risk follicular lymphoma and marginal zone lymphoma: A single-arm retrospective study(2025)
- → Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors(2025)